PRA Health Sciences (PRAH) Announces Earnings Results
PRA Health Sciences (NASDAQ:PRAH) released its quarterly earnings data on Tuesday. The medical research company reported $1.04 EPS for the quarter, beating the Zacks’ consensus estimate of $1.02 by $0.02, Bloomberg Earnings reports. The company had revenue of $568.80 million during the quarter, compared to the consensus estimate of $543.78 million. PRA Health Sciences had a net margin of 5.64% and a return on equity of 21.66%. PRA Health Sciences’s quarterly revenue was up 37.5% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.71 EPS.
Shares of PRA Health Sciences (NASDAQ PRAH) traded up $0.85 during midday trading on Wednesday, hitting $88.99. 496,167 shares of the stock were exchanged, compared to its average volume of 412,262. The firm has a market cap of $5,640.00, a P/E ratio of 49.99, a P/E/G ratio of 1.20 and a beta of 0.31. The company has a debt-to-equity ratio of 1.38, a current ratio of 1.01 and a quick ratio of 1.01. PRA Health Sciences has a fifty-two week low of $57.72 and a fifty-two week high of $95.90.
In other news, VP Linda Baddour sold 67,000 shares of the firm’s stock in a transaction that occurred on Tuesday, January 16th. The shares were sold at an average price of $90.27, for a total transaction of $6,048,090.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, EVP David W. Dockhorn sold 72,850 shares of the firm’s stock in a transaction that occurred on Thursday, December 28th. The stock was sold at an average price of $90.83, for a total transaction of $6,616,965.50. Following the sale, the executive vice president now owns 72,850 shares of the company’s stock, valued at approximately $6,616,965.50. The disclosure for this sale can be found here. Insiders have sold a total of 212,700 shares of company stock valued at $19,282,021 in the last 90 days. Insiders own 2.10% of the company’s stock.
ILLEGAL ACTIVITY WARNING: This piece of content was originally posted by Daily Political and is owned by of Daily Political. If you are accessing this piece of content on another domain, it was illegally copied and republished in violation of U.S. and international trademark & copyright law. The legal version of this piece of content can be viewed at https://www.dailypolitical.com/2018/02/21/pra-health-sciences-prah-announces-earnings-results.html.
PRA Health Sciences Company Profile
PRA Health Sciences, Inc is a contract research organization. The Company provides outsourced clinical development services to the biotechnology and pharmaceutical industries. The Company offers therapeutic services in areas of pharmaceutical development, including oncology, central nervous system, inflammation and infectious diseases.
Receive News & Ratings for PRA Health Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PRA Health Sciences and related companies with MarketBeat.com's FREE daily email newsletter.